Healthcare & Life Sciences Industry Updates

Google News – FDA (biotech/pharma) External News

Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback - Fierce Pharma

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA Recommends Two-Year Follow-Up for Gorlin Syndrome Study - Stock Titan

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Lilly, with new data, to seek FDA approval of obesity drug retatrutide - BioPharma Dive

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA clears Medicus Pharma's Phase 2b trial for SkinJect to treat Gorlin syndrome patients - Pluang

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Biotech experts want FDA drug reviews based on science, not politics - WTVB

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster - Fierce Pharma

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Aurobindo unit, China API maker dinged in latest round of FDA warning letters - Fierce Pharma

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Pharmalittle: We're reading about an FDA commish nominee, mRNA cancer vaccine results, and more - STAT

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Trump taps White House aide Heidi Overton as nominee for next FDA commissioner - Fierce Biotech

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA greenlights Regeneron drug for rare bone disease - pharmaphorum

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Trump nominates policy aide Overton to lead FDA - Pharma Voice

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Reports suggest Trump set to nominate Heidi Overton as FDA commissioner - FirstWord Pharma

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility - TradingView

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

FDA accepts Teva's NDA for ecopipam, grants priority review for pediatric Tourette syndrome - The Pharma Letter

news.google.com · 20 Aug 2026

Google News – FDA (biotech/pharma) External News

Why Oncolytics Biotech Just Cleared A Hurdle That Stalls Most Cancer Trials - Yahoo Finance Singapore

news.google.com · 20 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

Technology transforms health human resources management - hospitalnews.com

SPARSH Hospitals Appoints Kalappa K.B. as Group Chief Human Resources Officer - hrtoday.in

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Early Alert: Portrait Core Services Software Issue from GE HealthCare

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

BBC Inside Science

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback - Fierce Pharma

FDA Recommends Two-Year Follow-Up for Gorlin Syndrome Study - Stock Titan

Lilly, with new data, to seek FDA approval of obesity drug retatrutide - BioPharma Dive

FDA clears Medicus Pharma's Phase 2b trial for SkinJect to treat Gorlin syndrome patients - Pluang

Biotech experts want FDA drug reviews based on science, not politics - WTVB

FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster - Fierce Pharma

Aurobindo unit, China API maker dinged in latest round of FDA warning letters - Fierce Pharma

Pharmalittle: We're reading about an FDA commish nominee, mRNA cancer vaccine results, and more - STAT

Trump taps White House aide Heidi Overton as nominee for next FDA commissioner - Fierce Biotech

FDA greenlights Regeneron drug for rare bone disease - pharmaphorum

Trump nominates policy aide Overton to lead FDA - Pharma Voice

Reports suggest Trump set to nominate Heidi Overton as FDA commissioner - FirstWord Pharma

Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility - TradingView

FDA accepts Teva's NDA for ecopipam, grants priority review for pediatric Tourette syndrome - The Pharma Letter

Why Oncolytics Biotech Just Cleared A Hurdle That Stalls Most Cancer Trials - Yahoo Finance Singapore